You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Pediatrics/Children's Health Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 1 | Results 1 - 2 of 2

Efficacy of Recombinant Human Clara Cell 10 KDA Protein (CC10) Administered to Premature Neonates with Respiratory Distress Syndrome

Bronchopulmonary dysplasia (BPD) is a chronic lung disease of premature infants characterized by marked inflammation and alveolar hypoplasia.  Presently there are no known medications which prevent the development of BPD.   The purpose of the present study is to evaluate the ability of a single intratracheal dose of recombinant human CC10 to prevent the development of long-term respiratory complications and BPD in ventilated premature infants. 

Laura Madore, MD

Baystate Medical Center 759 Chestnut Street Springfield, MA 01199

Improving Outcome in Neonatal Abstinence Syndrome

The purpose of this research study is to compare treatment options for infants with Neonatal Abstinence Syndrome (NAS) due to narcotic exposure in the womb and evaluate the effects of treatment on long-term neurodevelopmental outcome at 18 months of age. The goal is to compare the two most commonly used drugs and see which requires fewer days in the hospital to complete treatment.  The study will also determine if genetic variations contribute to the severity of NAS.

Rachana Singh, MD

Baystate Children's Hospital
759 Chestnut Street
Springfield, MA 01199

Page 1 of 1 | Results 1 - 2 of 2